{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T04:34:10Z","timestamp":1777782850664,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,3,27]],"date-time":"2015-03-27T00:00:00Z","timestamp":1427414400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Community Health"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s10900-015-0016-2","type":"journal-article","created":{"date-parts":[[2015,3,26]],"date-time":"2015-03-26T15:36:23Z","timestamp":1427384183000},"page":"940-947","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Risk Factors Associated with HCV Among Opioid-Dependent Patients in a Multisite Study"],"prefix":"10.1007","volume":"40","author":[{"given":"M.","family":"Schulte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Hser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Saxon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hillhouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,27]]},"reference":[{"key":"16_CR1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/cid\/cis393","volume":"55","author":"RM Klevens","year":"2012","unstructured":"Klevens, R. M., Hu, D. J., Jiles, R., & Holmberg, S. D. (2012). Evolving epidemiology of hepatitis C virus in the United States. Clinical Infectious Diseases, 55, S3\u2013S9.","journal-title":"Clinical Infectious Diseases"},{"issue":"9791","key":"16_CR2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","volume":"378","author":"PK Nelson","year":"2011","unstructured":"Nelson, P. K., Mathers, B. M., Cowie, B., et al. (2011). Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: Results of systematic reviews. Lancet, 378(9791), 571\u2013583.","journal-title":"Lancet"},{"issue":"8","key":"16_CR3","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1478-3231.2011.02494.x","volume":"31","author":"E Chak","year":"2011","unstructured":"Chak, E., Talal, A. H., Sherman, K. E., Schiff, E. R., & Saab, S. (2011). Hepatitis C virus infection in USA: An estimate of true prevalence. Liver International, 31(8), 1090\u20131101.","journal-title":"Liver International"},{"key":"16_CR4","volume-title":"Hepatitis and liver cancer a national strategy for prevention and control of hepatitis B and C","author":"Institute of Medicine","year":"2010","unstructured":"Institute of Medicine. (2010). Hepatitis and liver cancer a national strategy for prevention and control of hepatitis B and C. Washington: National Academies Press."},{"issue":"25","key":"16_CR5","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMcp1006613","volume":"364","author":"HR Rosen","year":"2011","unstructured":"Rosen, H. R. (2011). Clinical practice. Chronic hepatitis C infection. The New England Journal of Medicine, 364(25), 2429\u20132438.","journal-title":"The New England Journal of Medicine"},{"issue":"6","key":"16_CR6","first-page":"552","volume":"34","author":"S Duan","year":"2013","unstructured":"Duan, S., Han, J., Tang, R. H., et al. (2013). Study on the incidence and risk factors of HCV infection among heroin addicts who were on methadone maintenance treatment in Dehong prefecture, Yunnan province. Zhonghua Liu Xing Bing Xue Za Zhi, 34(6), 552\u2013556.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"1","key":"16_CR7","doi-asserted-by":"crossref","first-page":"e1002876","DOI":"10.1371\/journal.pcbi.1002876","volume":"9","author":"G Magiorkinis","year":"2013","unstructured":"Magiorkinis, G., Sypsa, V., Magiorkinis, E., et al. (2013). Integrating phylodynamics and epidemiology to estimate transmission diversity in viral epidemics. PLoS Computational Biology, 9(1), e1002876.","journal-title":"PLoS Computational Biology"},{"issue":"4","key":"16_CR8","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.addbeh.2013.01.010","volume":"38","author":"MH Ng","year":"2013","unstructured":"Ng, M. H., Chou, J. Y., Chang, T. J., et al. (2013). High prevalence but low awareness of hepatitis C virus infection among heroin users who received methadone maintenance therapy in Taiwan. Addictive Behaviors, 38(4), 2089\u20132093.","journal-title":"Addictive Behaviors"},{"issue":"5","key":"16_CR9","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1046\/j.1365-2893.2003.00448.x","volume":"10","author":"GL Quaglio","year":"2003","unstructured":"Quaglio, G. L., Lugoboni, F., Pajusco, B., et al. (2003). Hepatitis C virus infection: prevalence, predictor variables and prevention opportunities among drug users in Italy. Journal of Viral Hepatitis, 10(5), 394\u2013400.","journal-title":"Journal of Viral Hepatitis"},{"issue":"2\u20133","key":"16_CR10","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.drugalcdep.2007.01.003","volume":"89","author":"A Neaigus","year":"2007","unstructured":"Neaigus, A., Gyarmathy, V. A., Miller, M., et al. (2007). Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors. Drug Alcohol Dependence, 89(2\u20133), 234\u2013243.","journal-title":"Drug Alcohol Dependence"},{"issue":"7","key":"16_CR11","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1360-0443.2012.03803.x","volume":"107","author":"J Bruneau","year":"2012","unstructured":"Bruneau, J., Roy, E., Arruda, N., Zang, G., & Jutras-Aswad, D. (2012). The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users. Addiction, 107(7), 1318\u20131327.","journal-title":"Addiction"},{"issue":"6","key":"16_CR12","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1521-0391.2013.12058.x","volume":"22","author":"P Roux","year":"2013","unstructured":"Roux, P., Fugon, L., Jones, J. D., & Comer, S. D. (2013). Hepatitis C infection in non-treatment-seeking heroin users: the burden of cocaine injection. The American Journal on Addictions, 22(6), 613\u2013618.","journal-title":"The American Journal on Addictions"},{"issue":"12","key":"16_CR13","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1086\/588297","volume":"46","author":"JJ Amon","year":"2008","unstructured":"Amon, J. J., Garfein, R. S., Ahdieh-Grant, L., et al. (2008). Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994\u20132004. Clinical Infectious Diseases, 46(12), 1852\u20131858.","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"16_CR14","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s11524-012-9728-0","volume":"90","author":"RS Garfein","year":"2013","unstructured":"Garfein, R. S., Rondinelli, A., Barnes, R. F., Cuevas, J., et al. (2013). HCV infection prevalence lower than expected among 18-40-year-old injection drug users in San Diego, CA. Journal of Urban Health, 90(3), 516\u2013528.","journal-title":"Journal of Urban Health"},{"issue":"1","key":"16_CR15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.drugalcdep.2006.09.018","volume":"88","author":"R Hallinan","year":"2007","unstructured":"Hallinan, R., Byrne, A., Agho, K., & Dore, G. J. (2007). Referral for chronic hepatitis C treatment from a drug dependency treatment setting. Drug Alcohol Dependence, 88(1), 49\u201353.","journal-title":"Drug Alcohol Dependence"},{"issue":"Suppl 2","key":"16_CR16","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1093\/cid\/cit305","volume":"57","author":"M Alavi","year":"2013","unstructured":"Alavi, M., Grebely, J., Micallef, M., Dunlop, A. J., et al. (2013). Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study. Clinical Infectious Diseases, 57(Suppl 2), S62\u2013S69.","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"16_CR17","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/jvh.12129","volume":"21","author":"J Iversen","year":"2014","unstructured":"Iversen, J., Grebely, J., Topp, L., Wand, H., Dore, G., & Maher, L. (2014). Uptake of hepatitis C treatment among people who inject drugs attending needle and syringe programs in Australia, 1999\u20132011. Journal of Viral Hepatitis, 21(3), 198\u2013207.","journal-title":"Journal of Viral Hepatitis"},{"issue":"18","key":"16_CR18","first-page":"357","volume":"62","author":"Centers for Disease Control and Prevention (CDC)","year":"2013","unstructured":"Centers for Disease Control and Prevention (CDC). (2013). Vital signs: evaluation of hepatitis C virus infection testing and reporting-eight US sites, 2005\u20132011. Morbidity and Mortality Weekly Report, 62(18), 357\u2013361.","journal-title":"Morbidity and Mortality Weekly Report"},{"issue":"18","key":"16_CR19","first-page":"362","volume":"62","author":"Centers for Disease Control and Prevention (CDC)","year":"2013","unstructured":"Centers for Disease Control and Prevention (CDC). (2013). Testing for HCV infection: An update of guidance for clinicians and laboratorians. Morbidity and Mortality Weekly Report, 62(18), 362\u2013365.","journal-title":"Morbidity and Mortality Weekly Report"},{"issue":"12","key":"16_CR20","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1111\/j.1537-2995.2005.00648.x","volume":"45","author":"S Laperche","year":"2005","unstructured":"Laperche, S., Elghouzzi, M. H., Morel, P., et al. (2005). Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing? Transfusion, 45(12), 1965\u20131972.","journal-title":"Transfusion"},{"issue":"3","key":"16_CR21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.1537-2995.2002.00052.x","volume":"42","author":"AS Muerhoff","year":"2002","unstructured":"Muerhoff, A. S., Jiang, L., Shah, D. O., et al. (2002). Detection of HCV core antigen in human serum and plasma with an automated chemiluminescent immunoassay. Transfusion, 42(3), 349\u2013356.","journal-title":"Transfusion"},{"issue":"2","key":"16_CR22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-3148.2002.00359.x","volume":"12","author":"A Widell","year":"2002","unstructured":"Widell, A., Molnegren, V., Pieksma, F., et al. (2002). Detection of hepatitis C core antigen in serum or plasma as a marker for hepatitis C viraemia in the serological window-phase. Transfusion Medicine, 12(2), 107\u2013113.","journal-title":"Transfusion Medicine"},{"issue":"1\u20132","key":"16_CR23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.drugalcdep.2012.08.002","volume":"128","author":"AJ Saxon","year":"2013","unstructured":"Saxon, A. J., Ling, W., Hillhouse, M., et al. (2013). Buprenorphine\/Naloxone and methadone effects on laboratory indices of liver health: A randomized trial. Drug Alcohol Dependence, 128(1\u20132), 71\u201376.","journal-title":"Drug Alcohol Dependence"},{"issue":"4","key":"16_CR24","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1037\/0893-164X.9.4.242","volume":"9","author":"R Needle","year":"1995","unstructured":"Needle, R., Fisher, D. G., Weatherby, N., et al. (1995). Reliability of self-reported HIV risk behaviors of drug users. Psychology of Addictive Behaviors, 9(4), 242\u2013250.","journal-title":"Psychology of Addictive Behaviors"},{"issue":"4","key":"16_CR25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0149-7189(94)90035-3","volume":"17","author":"NL Weatherby","year":"1992","unstructured":"Weatherby, N. L., Needle, R., & Cesari, C. (1992). Validity of self-reported drug use among injection drug users and crack cocaine users recruited through street outreach. Evaluation and Program Planning, 17(4), 347\u2013355.","journal-title":"Evaluation and Program Planning"},{"issue":"6","key":"16_CR26","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware","year":"1992","unstructured":"Ware, J. E., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Medical Care, 30(6), 473\u2013483.","journal-title":"Medical Care"},{"issue":"4902","key":"16_CR27","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.2523562","volume":"244","author":"QL Choo","year":"1989","unstructured":"Choo, Q. L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W., & Houghton, M. (1989). Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science, 244(4902), 359\u2013362.","journal-title":"Science"},{"issue":"28","key":"16_CR28","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.3748\/wjg.15.3462","volume":"15","author":"S Mueller","year":"2009","unstructured":"Mueller, S., Millonig, G., & Seitz, H. K. (2009). Alcoholic liver disease and hepatitis C: A frequently underestimated combination. World Journal of Gastroenterology, 15(28), 3462\u20133471.","journal-title":"World Journal of Gastroenterology"},{"key":"16_CR29","unstructured":"Centers for Disease Control and Prevention (CDC). Viral hepatitis surveillance United States. ( http:\/\/www.cdc.gov\/hepatitis\/Statistics\/2012Surveillance\/PDFs\/2012HepSurveillanceRpt.pdf )."},{"issue":"2","key":"16_CR30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/002204261004000201","volume":"40","author":"SE Lankenau","year":"2010","unstructured":"Lankenau, S. E., Wagner, K. D., Jackson Bloom, J., Sanders, B., Hathazi, D., & Shin, C. (2010). The first injection event: Differences among heroin, methamphetamine, cocaine, and ketamine initiates. Journal of Drug Issues, 40(2), 241\u2013262.","journal-title":"Journal of Drug Issues"},{"issue":"3","key":"16_CR31","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.drugpo.2006.08.004","volume":"18","author":"C Morissette","year":"2007","unstructured":"Morissette, C., Cox, J., De, P., et al. (2007). Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: Implications for HIV and hepatitis C prevention. International Journal of Drug Policy, 18(3), 204\u2013212.","journal-title":"International Journal of Drug Policy"},{"issue":"9","key":"16_CR32","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1473-3099(05)70216-4","volume":"5","author":"CW Shepard","year":"2005","unstructured":"Shepard, C. W., Finelli, L., & Alter, M. J. (2005). Global epidemiology of hepatitis C virus infection. The Lancet Infectious Diseases, 5(9), 558\u2013567.","journal-title":"The Lancet Infectious Diseases"},{"issue":"Suppl 1","key":"16_CR33","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S0376-8716(06)80006-2","volume":"82","author":"E Shapatava","year":"2006","unstructured":"Shapatava, E., Nelson, K. E., Tsertsvadze, T., & del Rio, C. (2006). Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia. Drug and Alcohol Dependence, 82(Suppl 1), S35\u2013S38.","journal-title":"Drug and Alcohol Dependence"},{"issue":"9","key":"16_CR34","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/01.aids.0000171412.61360.f8","volume":"19","author":"HM G\u00f6tz","year":"2005","unstructured":"G\u00f6tz, H. M., van Doornum, G., Niesters, H. G., den Hollander, J. G., Thio, H. B., & de Zwart, O. (2005). A cluster of acute hepatitis C virus infection among men who have sex with men\u2014results from contact tracing and public health implications. AIDS, 19(9), 969\u2013974.","journal-title":"AIDS"},{"issue":"3","key":"16_CR35","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s10620-012-2392-0","volume":"58","author":"M Lisker-Melman","year":"2013","unstructured":"Lisker-Melman, M., & Walewski, J. L. (2013). The impact of ethnicity on hepatitis C virus treatment decisions and outcomes. Digestive Diseases and Science, 58(3), 621\u2013629.","journal-title":"Digestive Diseases and Science"},{"issue":"1","key":"16_CR36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","volume":"13","author":"JM Micallef","year":"2006","unstructured":"Micallef, J. M., Kaldor, J. M., & Dore, G. J. (2006). Spontaneous viral clearance following acute hepatitis C infection: A systematic review of longitudinal studies. Journal of Viral Hepatitis, 13(1), 34\u201341.","journal-title":"Journal of Viral Hepatitis"},{"issue":"3","key":"16_CR37","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.socscimed.2008.10.011","volume":"68","author":"C Lelutiu-Weinberger","year":"2009","unstructured":"Lelutiu-Weinberger, C., Pouget, E. R., & DesJarlais, D. D. (2009). A meta-analysis of the hepatitis C virus distribution in diverse racial\/ethnic drug injector groups. Social Science and Medicine, 68(3), 579\u2013590.","journal-title":"Social Science and Medicine"},{"issue":"6","key":"16_CR38","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1017\/S0950268811001750","volume":"140","author":"A Castro-S\u00e1nchez","year":"2012","unstructured":"Castro-S\u00e1nchez, A., Shkedy, Z., & Hens, N. (2012). Estimating the force of infection for HCV in injecting drug users using interval-censored data. Epidemiology and Infection, 140(6), 1064\u20131074.","journal-title":"Epidemiology and Infection"},{"issue":"4","key":"16_CR39","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/003335491212700409","volume":"127","author":"L Gelberg","year":"2012","unstructured":"Gelberg, L., Robertson, M. J., Arangua, L., et al. (2012). Prevalence, distribution, and correlates of hepatitis C virus infection among homeless adults in Los Angeles. Public Health Reports, 127(4), 407\u2013421.","journal-title":"Public Health Reports"},{"issue":"6","key":"16_CR40","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1360-0443.2008.02188.x","volume":"103","author":"DM Novick","year":"2008","unstructured":"Novick, D. M., & Kreek, M. J. (2008). Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients. Addiction, 103(6), 905\u2013918.","journal-title":"Addiction"}],"container-title":["Journal of Community Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10900-015-0016-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10900-015-0016-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10900-015-0016-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T12:39:27Z","timestamp":1566477567000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10900-015-0016-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,27]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["16"],"URL":"https:\/\/doi.org\/10.1007\/s10900-015-0016-2","relation":{},"ISSN":["0094-5145","1573-3610"],"issn-type":[{"value":"0094-5145","type":"print"},{"value":"1573-3610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,27]]}}}